$20.87
13.18% today
Nasdaq, Oct 31, 09:00 pm CET
ISIN
US63009J1079
Symbol
NBTX

Nanobiotix - ADR Stock price

$20.87
+1.98 10.48% 1M
+17.48 515.63% 6M
+18.00 627.18% YTD
+16.71 401.68% 1Y
+16.91 427.02% 3Y
+7.37 54.59% 5Y
+7.37 54.59% 10Y
+7.37 54.59% 20Y
Nasdaq, Closing price Fri, Oct 31 2025
+2.43 13.18%
ISIN
US63009J1079
Symbol
NBTX
Industry

Key metrics

Basic
Market capitalization
$860.5m
Enterprise Value
$884.9m
Net debt
$24.4m
Cash
$33.3m
Shares outstanding
48.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
103.9 | 18.9
EV/Sales
106.9 | 19.5
EV/FCF
negative
P/B
negative
Financial Health
Equity Ratio
-97.5%
Return on Equity
103.7%
ROCE
246.0%
ROIC
-
Debt/Equity
-0.7
Financials (TTM | estimate)
Revenue
$8.3m | $45.5m
EBITDA
$-49.4m | $-51.2m
EBIT
$-50.8m | $-44.3m
Net Income
$-59.7m | $-41.7m
Free Cash Flow
$-36.6m
Growth (TTM | estimate)
Revenue
-80.2% | 438.7%
EBITDA
-84.4% | 33.8%
EBIT
-75.3% | 44.0%
Net Income
-54.3% | 47.1%
Free Cash Flow
-1,956.2%
Margin (TTM | estimate)
Gross
-
EBITDA
-596.6% | -112.4%
EBIT
-613.9%
Net
-721.7% | -91.6%
Free Cash Flow
-442.2%
More
EPS
$-1.3
FCF per Share
$-0.8
Short interest
0.1%
Employees
108
Rev per Employee
$-120.0k
Show more

Is Nanobiotix - ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Nanobiotix - ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Nanobiotix - ADR forecast:

11x Buy
92%
1x Hold
8%

Analyst Opinions

12 Analysts have issued a Nanobiotix - ADR forecast:

Buy
92%
Hold
8%

Financial data from Nanobiotix - ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
8.28 8.28
80% 80%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 24 24
3% 3%
292%
- Research and Development Expense 37 37
22% 22%
447%
-49 -49
84% 84%
-596%
- Depreciation and Amortization 1.44 1.44
35% 35%
17%
EBIT (Operating Income) EBIT -51 -51
75% 75%
-614%
Net Profit -60 -60
54% 54%
-721%

In millions USD.

Don't miss a Thing! We will send you all news about Nanobiotix - ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Nanobiotix - ADR Stock News

Neutral
GlobeNewsWire
about 15 hours ago
PARIS and CAMBRIDGE, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company''), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced that it has entered into a royalty-based financing agreement with HealthCare Royalty (“HCRx...
Neutral
GlobeNewsWire
about one month ago
Data presented at the 2025 Annual Meeting of the American Society for Radiation Oncology (ASTRO) on October 1 st
Neutral
GlobeNewsWire
about one month ago
PARIS and CAMBRIDGE, Mass., Sept. 30, 2025 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO - NASDAQ: NBTX - the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, provided an update on operational progress and announced its half year financial results for the six-month ...
More Nanobiotix - ADR News

Company Profile

Nanobiotix SA engages in the development of nanoparticle-based technologies for the treatment of cancer. The company's technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells. It also engages in the development of magnetic particles and laser activated nanoparticles for the treatment and diagnosis of cancer. The company was founded by Laurent Lévy and Abdel Kader Boussaha on March 4, 2003 and is headquartered in Paris, France.

Head office France
CEO Laurent Lévy
Employees 108
Founded 2003
Website www.nanobiotix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today